Godavari Biorefineries Secures European Patent Validation for Anti-Cancer Molecule in Spain, UK, and EU

Mumbai, July 7, 2025 — Godavari Biorefineries Ltd (BSE: 544279 | NSE: GODAVARIB) announced the successful validation of its European patent for a novel anti-cancer molecule in Spain, the United Kingdom, and under the Unitary Patent system covering multiple EU member states.

Strategic Milestone in Global Oncology Innovation

The patented molecule, developed under Godavari’s dedicated Anti-Cancer Research Segment, has shown promising results in targeting both cancer cells and cancer stem cells, especially in breast and prostate cancers. Preclinical animal studies have demonstrated encouraging efficacy and safety profiles, and the molecule is currently undergoing Phase 1a clinical trials involving both healthy volunteers and patients with advanced solid tumors.

“This patent validation marks a significant milestone in our journey toward advancing original, high-quality scientific research,” said Sangeeta Srivastava, Executive Director of Godavari Biorefineries Limited. “It reflects the dedication of our teams and our aspiration to contribute meaningfully to global knowledge and innovation.”

Company Focus and Global Reach

This development strengthens Godavari’s scientific presence across Europe and reinforces its R&D-backed growth strategy. The company’s biotech subsidiary, Sathgen Therapeutics, is spearheading the clinical development of this anti-cancer molecule along with other novel therapies for cancer and viral diseases.

Godavari Biorefineries exports to over 20 countries and has built strong connections with global research institutions, further amplifying its biotech ambitions. This scientific diversification adds to its core leadership in ethanol, bio-based chemicals, and renewable materials derived from agricultural feedstocks.

Godavari Biorefineries Stock Performance

As of 9:35 AM IST, Godavari Biorefineries shares have gained 0.078% on July 7, 2025, trading at ₹256.95 in the NSE. Godavari Biorefineries shares have dipped 25% in the last year, 19.06% in the year-to-date, and down 9.09% in the previous month.

Godavari Biorefineries – Company Overview

Godavari Biorefineries Ltd is a listed company on both BSE and NSE and is a recognised leader in renewable chemicals and biofuels. It operates with a deep commitment to sustainability and innovation, playing a pivotal role in advancing green chemistry, circular economy practices, and translational health research.

REF: https://www.bseindia.com/xml-data/corpfiling/AttachLive/0b54a344-36e3-4a4d-b3e0-f80c4319152e.pdf

Disclaimer:  At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations